Landrum Kyle 4

What Happened Kyle Landrum, Chief Production Officer of Trulieve Cannabis Corp. (TRUL), received equity awards on March 13, 2026: 58,594 restricted stock units (RSUs) and 41,668 derivative option-style awards. Both grants show an acquisition price of $0.00 (typical for compensation grants). Combined, the awards represent potential ownership of 100,262 subordinate voting shares if/when vested and, for options, exercised.

Key Details

• Transaction date: March 13, 2026; Form 4 filed March 17, 2026 (filed within the two-business-day window).
• Awards: 58,594 RSUs (grant price $0.00) and 41,668 derivative/option awards (grant price $0.00).
• Vesting/terms: RSUs — 50% vest on Dec 1, 2027, remaining 50% on Dec 1, 2028 (F1). Options — become exercisable in three annual installments: one‑third on Dec 1, 2026, one‑third on Dec 1, 2027, and one‑third on Dec 1, 2028 (F2).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Transaction code: A (award/grant). No sale or open‑market purchase reported.
• No indication in the provided data of a 10b5-1 plan, tax‑withholding share surrender, or late filing.

Context RSUs are a contingent right to receive company shares when they vest; option awards give the right to purchase shares once they become exercisable under the stated schedule. These types of grants are typically part of executive compensation and do not, by themselves, indicate a personal cash purchase or an immediate market transaction.